Individuals Stopping Slimming Medications Gain Back Pounds Four Times Faster Compared to People Using Diet and Exercise

New research indicates that people who stop using new GLP-1 drugs like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who stop conventional lifestyle plans.

Findings released in a prominent medical journal demonstrates that while overweight people can lose about a fifth of their body weight while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing these treatments must be cognizant of the risk of fast rebound weight gain when the therapy is stopped," warns expert Dr. Susan Jebb.

This pace of regain implies a return to pre-treatment mass within about 18 months.

Weighing Approaches

The study, which reviewed 37 of studies involving thousands of patients, compared the outcomes of these new drugs with other pills.

Scientists emphasize that individuals who shed pounds through dieting usually have a slower weight regain—approximately 100 grams monthly—post-intervention.

Understanding the Quick Rebound

Nutrition scientists believe the mode of action of the jabs explains the amplified weight return.

These medications imitate a natural hormone called glucagon-like peptide-1, which controls hunger.

"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the body to produce less of its own natural hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Withdrawal of this GLP-1 'fix' means appetite is unsuppressed, making excessive eating much more probable."

An Ongoing Issue?

Health authorities recommend the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Many experts argue that, given the significant potential of weight regain, the therapy is often long-term.

This view is reinforced by pharmaceutical companies, who note that the findings "underscore the persistent nature of excess weight," similar to managing conditions like diabetes.

Patient Accounts

People who have come off the medication explain a sudden return of hunger.

"It felt as if a trigger that goes on and I was suddenly ravenous," described one woman.

The struggle is worsened if individuals have not developed permanent lifestyle or habit changes during treatment.

Growing Adoption

Figures indicate that a significant number of people in the UK have used weight-loss jabs in the past year, with desire continuing to grow.

• Use is more common among females than males.
• The middle-aged demographic shows the greatest level of interest.
• Many access the drugs through private healthcare rather than public health services.

Ultimately, experts stress that while GLP-1 drugs are powerful tools for weight loss, they are not a standalone solution and lasting health benefits likely depends on integrated behavioural changes.